Skip to main content
. 2022 Feb 19;9(3):208–218. doi: 10.1093/nop/npac011

Table 1.

Participant Demographic and Medical Characteristics

Characteristic Mean (SD) Range
Age at diagnosisa 49.55 (11.02) 29-74
Age at assessmenta 55.85 (10.62) 36-80
Time between diagnosis and assessmentb 80.68 (80.33) 2-445
Time between RT and assessmentb 23.79 (32.85) 0-93
Educationa 15.78 (4.41) 5-26
Tumor volume (cm3) 22.89 (18.42) 1-77
Radiation prescription dose (median [SD]) 5468.02 (530.52) 5000-7000
ROI mean radiation dose
 Cerebellum 1221.39 (968.20) 16-4291
 Dorsal frontal 1367.42 (1179.77) 56-4462
 Hippocampi 1922.84 (1234.17) 32-3932
 Parietal-occipital 936.23 (871.60) 123-3142
 Subcortical 1665.60 (1017.30) 63-3936
 Ventral frontal 2128.76 (1556.01) 22-4832
ROI D50 radiation dose
 Cerebellum 1082.25 (944.67) 16-4485
 Dorsal frontal 1123.65 (1402.60) 43-4951
 Hippocampi 1593.30 (1238.04) 31-4130
 Parietal-occipital 776.12 (843.27) 58-3003
 Subcortical 1467.12 (1105.28) 54-4365
 Ventral frontal 2097.50 (1682.50) 21-5371
Radiation fractions 28.12 (2.90) 25-35
N (%)
Sex (male) 21 (52.50)
Marital status (married) 26 (65.00)
Surgery (yes) 29 (72.50)
Antiepileptic medication (yes) 9 (22.50)
Tumor grade
 I 16 (40.00)
 II 12 (30.00)
 Unresected 11 (27.50)
 Unknown 1 (2.50)
Tumor location
 Frontal 13 (32.50)
 Suprasellar 11 (27.50)
 Temporal 9 (22.50)
 Occipital 3 (7.50)
 Parietal 3 (7.50)
 Multiple locations 1 (2.50)
Tumor laterality
 Left 18 (45.00)
 Right 17 (42.50)
 Midline 5 (12.50)
Radiation technique
 3DCRT 2 (5.00)
 IMRT 28 (70.00)
 VMAT 10 (25.00)

Abbreviations: 3DCRT, three-dimensional conformal RT therapy; assessment, neurocognitive assessment; IMRT, intensity-modulated RT therapy (ie, step-and-shoot); VMAT, volumetric modulated arc therapy.

aYears.

bMonths.